By Hannah Green Last year, Massachusetts’ life sciences industry saw its slowest job growth since 2017 as the industry faced economic headwinds. The Bay State’s biopharma workforce consisted of 116,937 employees in 2023, according to the latest “Industry Snapshot” report put out by the Massachusetts Biotechnology Council, or MassBio, on Tuesday. The trade group found that […]
By Lucia Maffei Women are increasingly joining the ranks of angel investors, and now make up almost half of angel investors nationwide, according to a new report. Last year, women angels represented 46.7% of the angel market, marking the third year in a row of increased participation. Women angels accounted for 39.5% of the market in […]
By Hannah Green Venture capital funding to life sciences companies appears to be rebounding nationally after a few down years, according to new data from Pitchbook and the National Venture Capital Association. But that’s not the case among Massachusetts life sciences companies. Nationally, life sciences companies brought in $19.3 billion in the first six months of 2024. Last […]
By Hannah Green The former CEO of Dyne Therapeutics Inc. has joined Forbion as the life sciences venture capital firm announced plans to expand its U.S. presence by opening a Boston office. Josh Brumm, formerly of Dyne and a newly named general partner at Forbion, said the Boston office “really does have a chance to impact the […]
